Foresee Pharmaceuticals to Present at the American Heart Association Annual Meeting Focusing on its ALDH2 activator FP-045 in Pulmonary Hypertension Associated with Interstitial Lung Disease

By / 30/10/2023

Foresee Pharmaceuticals, announced that the company will be presenting at the American Heart Association 2023 Annual Meeting taking place in Philadelphia, PA, from November 11-13, 2023.